Companies / Uganda
Uganda Opens ARVs, ACTs Facility
July 2006 | Product LaunchPrivate sector company Quality Chemicals has opened a US$50mn facility in Kampala, Uganda, manufacturing anti-retorviral drugs (ARVs) and artemisinin combiantion therapies (ACTs) for HIV/AIDS and malaria. The GLP and GMP-certifiable plant - a joint venture with Indian generics producer Cipla - is expected to begin full-scale operations in February 2007. Observers have remarked that the project is a significant coup for Uganda, which has been hailed for its efforts to slow the spread of AIDS. Investors had originally considered setting up the plant in South Africa or
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
